{
    "Trade/Device Name(s)": [
        "TD-4268 Blood Glucose Monitoring System",
        "TD-4268 Multi Blood Glucose Monitoring System"
    ],
    "Submitter Information": "TaiDoc Technology Corporation",
    "510(k) Number": "K120042",
    "Predicate Device Reference 510(k) Number(s)": [
        "K101635"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LFR",
        "NBW"
    ],
    "Summary Letter Date": "April 10, 2012",
    "Summary Letter Received Date": "April 23, 2012",
    "Submission Date": "January 2, 2012",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood",
        "Venous whole blood",
        "Neonatal whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "TD-4268 Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Glucose dehydrogenase method"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for TaiDoc TD-4268 Blood Glucose Monitoring System and TD-4268 Multi Blood Glucose Monitoring System for quantitative glucose measurement in whole blood",
    "Indications for Use Summary": "TD-4268 Blood Glucose Monitoring System is intended for quantitative measurement of glucose in fresh capillary whole blood by a single person for self-testing at home; TD-4268 Multi Blood Glucose Monitoring System is intended for quantitative measurement of glucose in capillary, venous, and neonatal whole blood for multiple patient use in professional healthcare settings",
    "fda_folder": "Clinical Chemistry"
}